Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-002439
Filing Date
2021-03-01
Accepted
2021-03-01 17:30:17
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27750
2 filename2.txt TEXT-EXTRACT 1710
  Complete submission text file 0000000000-21-002439.txt   40614
Mailing Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET, SUITE 205 SAN FRANCISCO CA 94158 (415) 660-5320
Nurix Therapeutics, Inc. (Filed for) CIK: 0001549595 (see all company filings)

EIN.: 270838048 | State of Incorp.: DE | Fiscal Year End: 1130
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations